Biolife Solutions (BLFS) Net Income towards Common Stockholders (2010 - 2025)

Biolife Solutions (BLFS) has 16 years of Net Income towards Common Stockholders data on file, last reported at $7.5 million in Q4 2025.

• Net Income towards Common Stockholders for Q4 2025 came in at $7.5 million, down 37.28% year-over-year; the trailing twelve-month figure through Mar 2026 was -$8.3 million (up 23.52% YoY), and the FY2025 annual result was $7.5 million, up 166.1% from the prior year.
• Net Income towards Common Stockholders advanced to $7.5 million in Q4 2025 per BLFS's latest filing, from -$15.8 million in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at $12.0 million in Q4 2024 and troughed at -$72.9 million in Q2 2022.
• A 5-year average of -$11.9 million and a median of -$10.2 million in 2024 frame the typical range for Net Income towards Common Stockholders.
• The sharpest annual moves came in 2022 and 2024: Net Income towards Common Stockholders slumped 13159.49% in 2022, then surged 189.78% in 2024.
• A 5-year view of Net Income towards Common Stockholders shows it stood at -$15.7 million in 2021, then sank by 212.41% to -$49.2 million in 2022, then jumped by 72.79% to -$13.4 million in 2023, then surged by 189.78% to $12.0 million in 2024, then tumbled by 37.28% to $7.5 million in 2025.
• Business Quant data shows BLFS's Net Income towards Common Stockholders at $7.5 million in Q4 2025, -$15.8 million in Q2 2025, and -$448000.0 in Q1 2025.